Hypervascular liver masses > 2 cm, and either serum alpha-fetoprotein (AFP) > 400 ng/ml, or [clinicaltrials_resource:145156532d30fa50593ec5238913461e]

Hypervascular liver masses > 2 cm, and either serum alpha-fetoprotein (AFP) > 400 ng/ml, or [clinicaltrials_resource:145156532d30fa50593ec5238913461e]